Novartis Corp

Urigen Pharmaceuticals is a biochemical research and development company focused on the creation of cardiovascular therapeutics. The company begins development at a stage of a known molecule or protein and applies its expertise in formulation, manufacturing, clinical development and regulatory affairs to create products that fill unmet medical needs. Urigen Pharmaceuticals has a series of technologies that allow the company to generate novel therapeutics to treat a wide range of diseases. The company s technologies are applied by its collaborators for the development of therapeutics to treat a variety of indications, including infectious diseases and cancer. In addition to its own products, it has developed a series of technologies that it licensed to biotechnology and pharmaceutical companies. Urigen Pharmaceuticals maintains a location in Burlingame, Calif.

Incyte Corporation is a Delaware-based drug discovery and development company with a growing pipeline of oral compounds to treat HIV, inflammation, cancer and diabetes. Incyte has created an agile, highly focused and efficient research organization that has launched and fully staffed three internal discovery programs. The company trades on NASDAQ under the symbol INCY. It is headquartered in Wilmington, Del.

Accolade Pharmaceuticals is a development-stage specialty biopharmaceutical company based in Wilmington, DE, focused on creating innovative treatments for atopic and inflammatory allergic conditions. The company is dedicated to re-purposing zafirlukast, a well-known Leukotriene Receptor Antagonist (LTRA) that is already approved and marketed worldwide under the name Accolate. By leveraging their expertise, Accolade Pharmaceuticals aims to offer promising new therapies for individuals suffering from allergic disorders. Their commitment to improving patient outcomes drives their research and development initiatives in the field of allergy treatments. Generated from the website